Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 446 entries
Sorted by: Best Match Show Resources per page
Characterization of resting state activity in MCI individuals.

PeerJ

Esposito R, Mosca A, Pieramico V, Cieri F, Cera N, Sensi SL.
PMID: 24010015
PeerJ. 2013 Aug 20;1:e135. doi: 10.7717/peerj.135. eCollection 2013.

Objectives. Aging is the major risk factor for Alzheimer Disease (AD) and Mild Cognitive Impairment (MCI). The aim of this study was to identify novel modifications of brain functional connectivity in MCI patients. MCI individuals were compared to healthy...

Cite
Esposito R, Mosca A, Pieramico V, et al. Characterization of resting state activity in MCI individuals. PeerJ. 2013;1:e135doi: 10.7717/peerj.135.
Esposito, R., Mosca, A., Pieramico, V., Cieri, F., Cera, N., & Sensi, S. L. (2013). Characterization of resting state activity in MCI individuals. PeerJ, 1e135. https://doi.org/10.7717/peerj.135
Esposito, Roberto, et al. "Characterization of resting state activity in MCI individuals." PeerJ vol. 1 (2013): e135. doi: https://doi.org/10.7717/peerj.135
Esposito R, Mosca A, Pieramico V, Cieri F, Cera N, Sensi SL. Characterization of resting state activity in MCI individuals. PeerJ. 2013 Aug 20;1:e135. doi: 10.7717/peerj.135. eCollection 2013. PMID: 24010015; PMCID: PMC3757508.
Copy Download .nbib Format: NLM
Spatial Localization and Quantitation of Androgens in Mouse Testis by Mass Spectrometry Imaging.

Analytical chemistry

Cobice DF, Livingstone DE, Mackay CL, Goodwin RJ, Smith LB, Walker BR, Andrew R.
PMID: 27676129
Anal Chem. 2016 Nov 01;88(21):10362-10367. doi: 10.1021/acs.analchem.6b02242. Epub 2016 Oct 14.

Androgens are essential for male development and reproductive function. They are transported to their site of action as blood-borne endocrine hormones but can also be produced within tissues to act in intracrine and paracrine fashions. Because of this, circulating...

Cite
Cobice DF, Livingstone DE, Mackay CL, et al. Spatial Localization and Quantitation of Androgens in Mouse Testis by Mass Spectrometry Imaging. Anal Chem. 2016;88(21):10362-10367doi: 10.1021/acs.analchem.6b02242.
Cobice, D. F., Livingstone, D. E., Mackay, C. L., Goodwin, R. J., Smith, L. B., Walker, B. R., & Andrew, R. (2016). Spatial Localization and Quantitation of Androgens in Mouse Testis by Mass Spectrometry Imaging. Analytical chemistry, 88(21), 10362-10367. https://doi.org/10.1021/acs.analchem.6b02242
Cobice, Diego F, et al. "Spatial Localization and Quantitation of Androgens in Mouse Testis by Mass Spectrometry Imaging." Analytical chemistry vol. 88,21 (2016): 10362-10367. doi: https://doi.org/10.1021/acs.analchem.6b02242
Cobice DF, Livingstone DE, Mackay CL, Goodwin RJ, Smith LB, Walker BR, Andrew R. Spatial Localization and Quantitation of Androgens in Mouse Testis by Mass Spectrometry Imaging. Anal Chem. 2016 Nov 01;88(21):10362-10367. doi: 10.1021/acs.analchem.6b02242. Epub 2016 Oct 14. PMID: 27676129; PMCID: PMC5102453.
Copy Download .nbib Format: NLM
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.

Oncotarget

Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R.
PMID: 26405159
Oncotarget. 2015 Sep 15;6(27):24581. doi: 10.18632/oncotarget.5663.

The Abstract is incorrect in PubMed. The corrected Abstract is provided here.

Cite
Janku F, Angenendt P, Tsimberidou AM, et al. Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget. 2015;6(27):24581doi: 10.18632/oncotarget.5663.
Janku, F., Angenendt, P., Tsimberidou, A. M., Fu, S., Naing, A., Falchook, G. S., Hong, D. S., Holley, V. R., Cabrilo, G., Wheler, J. J., Piha-Paul, S. A., Zinner, R. G., Bedikian, A. Y., Overman, M. J., Kee, B. K., Kim, K. B., Kopetz, E. S., Luthra, R., Diehl, F., Meric-Bernstam, F., & Kurzrock, R. (2015). Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget, 6(27), 24581. https://doi.org/10.18632/oncotarget.5663
Janku, Filip, et al. "Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies." Oncotarget vol. 6,27 (2015): 24581. doi: https://doi.org/10.18632/oncotarget.5663
Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R. Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget. 2015 Sep 15;6(27):24581. doi: 10.18632/oncotarget.5663. PMID: 26405159; PMCID: PMC4695208.
Copy Download .nbib Format: NLM
High yield, controlled synthesis of graphitic networks from dense micro emulsions.

Chemical communications (Cambridge, England)

Negro E, Dieci M, Sordi D, Kowlgi K, Makkee M, Koper GJ.
PMID: 25145795
Chem Commun (Camb). 2014 Oct 14;50(80):11848-51. doi: 10.1039/c4cc05455e.

We report on the production of Carbon Nano Networks (CNNs) from dense microemulsions in which catalyst nanoparticles have been synthesized. CNNs are 3D carbon networks, consisting of branches and junctions, and are mesoporous, graphitic, and conductive being suitable as...

Cite
Negro E, Dieci M, Sordi D, et al. High yield, controlled synthesis of graphitic networks from dense micro emulsions. Chem Commun (Camb). 2014;50(80):11848-51doi: 10.1039/c4cc05455e.
Negro, E., Dieci, M., Sordi, D., Kowlgi, K., Makkee, M., & Koper, G. J. (2014). High yield, controlled synthesis of graphitic networks from dense micro emulsions. Chemical communications (Cambridge, England), 50(80), 11848-51. https://doi.org/10.1039/c4cc05455e
Negro, E, et al. "High yield, controlled synthesis of graphitic networks from dense micro emulsions." Chemical communications (Cambridge, England) vol. 50,80 (2014): 11848-51. doi: https://doi.org/10.1039/c4cc05455e
Negro E, Dieci M, Sordi D, Kowlgi K, Makkee M, Koper GJ. High yield, controlled synthesis of graphitic networks from dense micro emulsions. Chem Commun (Camb). 2014 Oct 14;50(80):11848-51. doi: 10.1039/c4cc05455e. PMID: 25145795.
Copy Download .nbib Format: NLM
Comparative in vitro study of the effectiveness of Green tea extract and common storage media on periodontal ligament fibroblast viability.

European journal of dentistry

Adeli F, Zabihi E, Abedian Z, Gharekhani S, Pouramir M, Khafri S, Ghasempour M.
PMID: 27403063
Eur J Dent. 2016 Jul-Sep;10(3):408-412. doi: 10.4103/1305-7456.184158.

OBJECTIVE: Green tea extract (GTE) was shown to be effective in preserving periodontal ligament fibroblasts (PDLFs) of avulsed teeth. This study aimed at determining the potential of GTE in preserving the viability of PDLFs comparing with different storage media.MATERIALS...

Cite
Adeli F, Zabihi E, Abedian Z, et al. Comparative in vitro study of the effectiveness of Green tea extract and common storage media on periodontal ligament fibroblast viability. Eur J Dent. 2016;10(3):408-412doi: 10.4103/1305-7456.184158.
Adeli, F., Zabihi, E., Abedian, Z., Gharekhani, S., Pouramir, M., Khafri, S., & Ghasempour, M. (2016). Comparative in vitro study of the effectiveness of Green tea extract and common storage media on periodontal ligament fibroblast viability. European journal of dentistry, 10(3), 408-412. https://doi.org/10.4103/1305-7456.184158
Adeli, Fahimeh, et al. "Comparative in vitro study of the effectiveness of Green tea extract and common storage media on periodontal ligament fibroblast viability." European journal of dentistry vol. 10,3 (2016): 408-412. doi: https://doi.org/10.4103/1305-7456.184158
Adeli F, Zabihi E, Abedian Z, Gharekhani S, Pouramir M, Khafri S, Ghasempour M. Comparative in vitro study of the effectiveness of Green tea extract and common storage media on periodontal ligament fibroblast viability. Eur J Dent. 2016 Jul-Sep;10(3):408-412. doi: 10.4103/1305-7456.184158. PMID: 27403063; PMCID: PMC4926598.
Copy Download .nbib Format: NLM
Lachemilla mexiquense (Rosaceae), a new species from Mexico.

PhytoKeys

Morales-Briones DF.
PMID: 27212879
PhytoKeys. 2016 Mar 25;(62):25-32. doi: 10.3897/phytokeys.62.7953. eCollection 2016.

A new species of Lachemilla (Rosaceae), Lachemilla mexiquense D.F. Morales-B., from Mexico is described and illustrated. This species is similar to Lachemilla aphanoides by its tripartite leaves and glomerulate inflorescence with entirely glabrous flowers, but it differs by its...

Cite
Morales-Briones DF. Lachemilla mexiquense (Rosaceae), a new species from Mexico. PhytoKeys. 2016;(62):25-32doi: 10.3897/phytokeys.62.7953.
Morales-Briones, D. F. (2016). Lachemilla mexiquense (Rosaceae), a new species from Mexico. PhytoKeys, (62), 25-32. https://doi.org/10.3897/phytokeys.62.7953
Morales-Briones, Diego F. "Lachemilla mexiquense (Rosaceae), a new species from Mexico." PhytoKeys vol. ,62 (2016): 25-32. doi: https://doi.org/10.3897/phytokeys.62.7953
Morales-Briones DF. Lachemilla mexiquense (Rosaceae), a new species from Mexico. PhytoKeys. 2016 Mar 25;(62):25-32. doi: 10.3897/phytokeys.62.7953. eCollection 2016. PMID: 27212879; PMCID: PMC4856900.
Copy Download .nbib Format: NLM
Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues.

Asian Pacific journal of cancer prevention : APJCP

Binti Yusof NS, Ameli F, Sabrina Florence Ch, Mustangin M, Abd Rahman F, Masir N.
PMID: 28547939
Asian Pac J Cancer Prev. 2017 Apr 01;18(4):1045-1050. doi: 10.22034/APJCP.2017.18.4.1045.

Aim: Abnormal expression patterns of beta-tubulin isotypes may provide a molecular rationale for the behaviour of lymphoma subtypes. In the present study class II and III beta-tubulin expression was assessed in non-neoplastic and neoplastic lymphoid tissues with reference to...

Cite
Binti Yusof NS, Ameli F, Sabrina Florence Ch, et al. Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues. Asian Pac J Cancer Prev. 2017;18(4):1045-1050doi: 10.22034/APJCP.2017.18.4.1045.
Binti Yusof, N. S., Ameli, F., Sabrina Florence, C. h., Mustangin, M., Abd Rahman, F., & Masir, N. (2017). Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues. Asian Pacific journal of cancer prevention : APJCP, 18(4), 1045-1050. https://doi.org/10.22034/APJCP.2017.18.4.1045
Binti Yusof, Nor Syahida, et al. "Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues." Asian Pacific journal of cancer prevention : APJCP vol. 18,4 (2017): 1045-1050. doi: https://doi.org/10.22034/APJCP.2017.18.4.1045
Binti Yusof NS, Ameli F, Sabrina Florence Ch, Mustangin M, Abd Rahman F, Masir N. Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues. Asian Pac J Cancer Prev. 2017 Apr 01;18(4):1045-1050. doi: 10.22034/APJCP.2017.18.4.1045. PMID: 28547939; PMCID: PMC5494214.
Copy Download .nbib Format: NLM
NORE1A Regulates MDM2 Via β-TrCP.

Cancers

Schmidt ML, Calvisi DF, Clark GJ.
PMID: 27023610
Cancers (Basel). 2016 Mar 23;8(4). doi: 10.3390/cancers8040039.

Mouse Double Minute 2 Homolog (MDM2) is a key negative regulator of the master tumor suppressor p53. MDM2 regulates p53 on multiple levels, including acting as an ubiquitin ligase for the protein, thereby promoting its degradation by the proteasome....

Cite
Schmidt ML, Calvisi DF, Clark GJ. NORE1A Regulates MDM2 Via β-TrCP. Cancers (Basel). 2016;8(4)doi: 10.3390/cancers8040039.
Schmidt, M. L., Calvisi, D. F., & Clark, G. J. (2016). NORE1A Regulates MDM2 Via β-TrCP. Cancers, 8(4), . https://doi.org/10.3390/cancers8040039
Schmidt, M Lee, et al. "NORE1A Regulates MDM2 Via β-TrCP." Cancers vol. 8,4 (2016). doi: https://doi.org/10.3390/cancers8040039
Schmidt ML, Calvisi DF, Clark GJ. NORE1A Regulates MDM2 Via β-TrCP. Cancers (Basel). 2016 Mar 23;8(4). doi: 10.3390/cancers8040039. PMID: 27023610; PMCID: PMC4846848.
Copy Download .nbib Format: NLM
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.

Oncoimmunology

Meraviglia S, Lo Presti E, Tosolini M, La Mendola C, Orlando V, Todaro M, Catalano V, Stassi G, Cicero G, Vieni S, Fourniè JJ, Dieli F.
PMID: 29123962
Oncoimmunology. 2017 Jul 13;6(10):e1347742. doi: 10.1080/2162402X.2017.1347742. eCollection 2017.

γδ T cells usually infiltrate many different types of cancer, but it is unclear whether they inhibit or promote tumor progression. Moreover, properties of tumor-infiltrating γδ T cells and those in the corresponding normal tissue remain largely unknown. Here...

Cite
Meraviglia S, Lo Presti E, Tosolini M, et al. Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer. Oncoimmunology. 2017;6(10):e1347742doi: 10.1080/2162402X.2017.1347742.
Meraviglia, S., Lo Presti, E., Tosolini, M., La Mendola, C., Orlando, V., Todaro, M., Catalano, V., Stassi, G., Cicero, G., Vieni, S., Fourniè, J. J., & Dieli, F. (2017). Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer. Oncoimmunology, 6(10), e1347742. https://doi.org/10.1080/2162402X.2017.1347742
Meraviglia, S, et al. "Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer." Oncoimmunology vol. 6,10 (2017): e1347742. doi: https://doi.org/10.1080/2162402X.2017.1347742
Meraviglia S, Lo Presti E, Tosolini M, La Mendola C, Orlando V, Todaro M, Catalano V, Stassi G, Cicero G, Vieni S, Fourniè JJ, Dieli F. Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer. Oncoimmunology. 2017 Jul 13;6(10):e1347742. doi: 10.1080/2162402X.2017.1347742. eCollection 2017. PMID: 29123962; PMCID: PMC5665062.
Copy Download .nbib Format: NLM
The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Diels J, Angermund R, Schroeder M, Worbes-Cerezo M, Thompson G.
PMID: 27200590
Value Health. 2014 Nov;17(7):A334. doi: 10.1016/j.jval.2014.08.639. Epub 2014 Oct 26.

No abstract available.

Cite
Diels J, Angermund R, Schroeder M, et al. The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM). Value Health. 2014;17(7):A334doi: 10.1016/j.jval.2014.08.639.
Diels, J., Angermund, R., Schroeder, M., Worbes-Cerezo, M., & Thompson, G. (2014). The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A334. https://doi.org/10.1016/j.jval.2014.08.639
Diels, J, et al. "The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A334. doi: https://doi.org/10.1016/j.jval.2014.08.639
Diels J, Angermund R, Schroeder M, Worbes-Cerezo M, Thompson G. The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM). Value Health. 2014 Nov;17(7):A334. doi: 10.1016/j.jval.2014.08.639. Epub 2014 Oct 26. PMID: 27200590.
Copy Download .nbib Format: NLM
Corrigendum: Abiotic ligation of DNA oligomers templated by their liquid crystal ordering.

Nature communications

Fraccia TP, Smith GP, Zanchetta G, Paraboschi E, Yi Y, Walba DM, Dieci G, Clark NA, Bellini T.
PMID: 26081555
Nat Commun. 2015 Jun 17;6:7463. doi: 10.1038/ncomms8463.

No abstract available.

Cite
Fraccia TP, Smith GP, Zanchetta G, et al. Corrigendum: Abiotic ligation of DNA oligomers templated by their liquid crystal ordering. Nat Commun. 2015;6:7463doi: 10.1038/ncomms8463.
Fraccia, T. P., Smith, G. P., Zanchetta, G., Paraboschi, E., Yi, Y., Walba, D. M., Dieci, G., Clark, N. A., & Bellini, T. (2015). Corrigendum: Abiotic ligation of DNA oligomers templated by their liquid crystal ordering. Nature communications, 67463. https://doi.org/10.1038/ncomms8463
Fraccia, Tommaso P, et al. "Corrigendum: Abiotic ligation of DNA oligomers templated by their liquid crystal ordering." Nature communications vol. 6 (2015): 7463. doi: https://doi.org/10.1038/ncomms8463
Fraccia TP, Smith GP, Zanchetta G, Paraboschi E, Yi Y, Walba DM, Dieci G, Clark NA, Bellini T. Corrigendum: Abiotic ligation of DNA oligomers templated by their liquid crystal ordering. Nat Commun. 2015 Jun 17;6:7463. doi: 10.1038/ncomms8463. PMID: 26081555; PMCID: PMC5784275.
Copy Download .nbib Format: NLM
Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Thilakarathne P, Diels J, van Sanden S, Liwing J, Van Agthoven M, Chirita O, Nahi H.
PMID: 27201764
Value Health. 2014 Nov;17(7):A545-6. doi: 10.1016/j.jval.2014.08.1767. Epub 2014 Oct 26.

No abstract available.

Cite
Thilakarathne P, Diels J, van Sanden S, et al. Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden. Value Health. 2014;17(7):A545-6doi: 10.1016/j.jval.2014.08.1767.
Thilakarathne, P., Diels, J., van Sanden, S., Liwing, J., Van Agthoven, M., Chirita, O., & Nahi, H. (2014). Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A545-6. https://doi.org/10.1016/j.jval.2014.08.1767
Thilakarathne, P, et al. "Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A545-6. doi: https://doi.org/10.1016/j.jval.2014.08.1767
Thilakarathne P, Diels J, van Sanden S, Liwing J, Van Agthoven M, Chirita O, Nahi H. Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden. Value Health. 2014 Nov;17(7):A545-6. doi: 10.1016/j.jval.2014.08.1767. Epub 2014 Oct 26. PMID: 27201764.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 446 entries